Covid-19 Delta outbreak: Lockdown likely to be for weeks, Prof David Skegg says
David Skegg believes New Zealand’s Delta outbreak could mean a long lockdown – and says the fight against the virus will go on for years.
He said he had not been closely working on the latest cases but “as an uniformed person, it is unlikely the lockdown will end next Tuesday. It’ll be a matter of weeks I fear,” Skegg told the Health select committee this afternoon.
Skegg told the committee that opening borders would mean more outbreaks of Covid-19.
“Let me be completely frank – when we reopen the border, things are going to get tough.
“Things will get more difficult. When we start reopening the borders, we are going to have outbreaks of Covid-19 and they’re going to be difficult to control.
“We are going to be at war with this virus for years,” Skegg said.
The Health committee is discussing NZ’s reopening strategy and the latest outbreak.
“Our number one priority is to stamp out this outbreak that we are experiencing, and our other priority is to vaccinate as many people as possible,” Skegg said.
National’s Covid-19 spokesman Chris Bishop asked Skegg what sort of vaccination coverage is needed to reopen to the world.
“It didn’t make a lot of sense to pluck a figure out of the air like the Australians have like 70 per cent or 80 per cent,” Skegg said.
Regarding Australian Prime Minister Scott Morrison’s comments about New Zealand’s elimination strategy, Skegg said he “thought the comments from Scott Morrison were pretty inappropriate”.
Skegg said the more people vaccinated the better.
“However high the vaccination coverage, we will need to take other measures,” Skegg said.
“There is no simple answer to that because vaccination is only one of the things in the mix,” Skegg said.
Skegg said that even with over 90 per cent of the population vaccinated, we would still rely on other measures like testing.
Vaccination was not the only thing that would determine reopening, he said. Other things like the number of people entering the country with Covid-19 would also have an impact.
Act leader David Seymour asked the committee about booster shots.
STORY CONTINUES AFTER LIVE BLOG
Prof Nikki Turner, of the University of Auckland, said the evidence on when boosters would be needed was unclear. Evidence so far suggested immunocompromised people were likely to need boosters first
“The early data coming through is that some immunocompromised people are likely to see waning immunity first.
“We are expecting at some stage we will need boosting, but we do not know when.”
Skegg said the Delta variant makes him “less optimistic that next year we will be able to continue controlling outbreaks by testing and contact tracing alone.”
This is because the period between infection and becoming symptomatic is so short, it is very difficult to contact trace.
Turner discussed why it was important the Government was now extending the time between first and second doses of the vaccine.
She said that one dose of the vaccine provided people with significant protection.
“In the end our priority is if we do get community transmission we want as many people as possible protected against severe disease,” Turner said.
Turner said that the vaccine is still quite “difficult” for primary care providers to manage, because of its temperature requirements and other issues. This has made it more difficult to bring GPs and pharmacies online.
Skegg said the country will have to get more used to using the bluetooth function of tracing if we’re to get on top of reopening.
“That’s the kind of thing we’re going to really lift our game on,” Skegg said.
Turner said the Government could look at using other non-Pfizer vaccines in future, if the evidence suggested they were worthwhile.
“We need to watch this space,” Turner said.
Turner said that for the small number of people who had a bad reaction to the Pfizer vaccine, the Government would look to use other vaccines, likely the Jansen vaccine.
Source: Read Full Article